Cellectis SA CMVLF
Trading Information
- Previous Close Price
- $0.97
- Day Range
- $0.97–1.02
- 52-Week Range
- $0.97–5.04
- Bid/Ask
- $0.93 / $1.25
- Shares Outstanding
- 100.73M
- Market Cap
- $97.12M
- Volume/Avg
- 13,100 / 4,882
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.71
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 229
- Website
- https://www.cellectis.com
Valuation
|
Metric
|
CMVLF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.37 |
Price/Sales | 1.71 |
Price/Cash Flow | — |
Price/Earnings
CMVLF
Financial Strength
|
Metric
|
CMVLF
|
|---|---|
Quick Ratio | 1.34 |
Current Ratio | 1.37 |
Interest Coverage | −8.09 |
Quick Ratio
CMVLF
Profitability
|
Metric
|
CMVLF
|
|---|---|
Return on Assets (Normalized) | −23.36% |
Return on Equity (Normalized) | −98.47% |
Return on Invested Capital (Normalized) | −44.58% |
Return on Assets
CMVLF
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|NjG?fm | LOCK|GT^@? | $133B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|mw#@dF< | LOCK|<<%BV | $83B | |||
| Moderna Inc
MRNA
| LOCK|&C%XG% | LOCK|m?f | $80B | |||
| argenx SE ADR
ARGX
| LOCK|HGXl<M! | LOCK|Zv | $55B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|?L$p>L | LOCK|!zL | $45B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|h>$<!%# | LOCK|@HFJ | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|dPPR?V^q | LOCK|%<!kZ | $28B | |||
| Incyte Corp
INCY
| LOCK|gf>y!q | LOCK|@$ | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|tfr?$b | LOCK|l#n | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|st&b?Sc | LOCK|L^ | $14B |
United States